The present study throws light on the scholarly communication of three leading countries in the field of pharmaceutical research as reflected in SCOPUS database during 1998-2017. In terms of publication output, United States with two leading Asian countries, China and India leads with 40.54 per cent share of the global research publication share in pharmaceutical sciences. The global outcome of scholarly communication in the field of pharmaceutical research is 1395221. The study mainly focuses both on qualitative and quantitative research growth of United States, China and India in terms of output of scholarly communication, citation impact, relative research effort, common sources used for publications and research collaboration. The growth pattern of three leading countries is highly chaotic. The relative research effort of India and China increased during 2008-2017 while in United States, it was decreased. Bioorganic and Medicinal Chemistry, Tetrahedron Letters and Tetrahedron are the common source of communication in these three countries. All the three countries show the positive shift in international collaboration during 1998-2002 to 2012-2017 in pharmaceutical research.
INTRODUCTION
The main purpose of any research is discovery, invention, research and development for the benefit of mankind. The main aim of pharmaceutical research is invention of new drugs to eradicate illness from the society. The pharmaceutical research is a boon for the mankind. An exponential growth in pharmaceutical research has been found during the last four decades. From drug discovery to its successful therapeutic outcomes, pharmaceutical field involves many disciplines such as chemistry, biology, pharmaceutics and biotechnology 1 . The impact of pharmaceutical research is directly related to cure the lives of human beings and animals from various diseases. Scientometrics plays a vital role in the assessment of scholarly communication. It is a technique which is used to analyse both the quantity and quality of scholarly communications using various scientometric indicators. The assessment of scholarly communication is a challenging task.
Olmeda-Gomez 2 , et al., accessed the Pharmacology research output of world as indexed in Scopus database. In terms of quantitative and qualitative research, North America and Western Europe leads in Pharmacology research. However, North Africa leads in receiving citation from foreign countries other than domestic citations. Sweileh China's research output and share has shown a steady increase over the research period that is during 2001 to 2011. During the period, other western countries have not shown significant difference in terms of bibliometric indicators as their research has reached its peak ten years ago. Alhaider 5 , et al. made a qualitative and quantitative assessment of research of Saudi Arabia in the field of pharmaceutical sciences as indexed in SCOPUS database. Saudi Arabia research growth increased during the research period of 2001-2010 in terms of publications with annual average growth rate of 14.2 per cent. Saudi Arabia published a largest share with Egypt in terms of international collaboration followed by USA, India and UK. Mulimani and Hadagali 6 analysed the research growth of BRICS countries in the field of pharmacy and pharmacology as indexed in Web of Science, a multidisciplinary bibliographic database during 2001to 2016 using various scientometric indicators. China has shown a significant growth during the period of study and may be a strong competitor for developed countries like USA in terms of research output. Verma and Shukla 7 analysed the research trend of information literacy of selected countries in terms of annual growth rate, compound annual growth rate, doubling time, most prolific authors and found that maximum publications are in 2016 and United States is the maximum contributor with 5770 publication followed by United Kingdom with 1028 publications. Roy 8 evaluated the growth rate, pattern of authorship and collaboration trend and most prolific researchers in the field of biological sciences during 1901-1947 and found that growth rate was very slow due to inadequate research institutes in early decade. Das, et al 9 analysed the scholarly communications of pharmaceutical research in India during 1998-2017 to access the quality of research in terms of total publication, total citation received, prolific authors and institutions and found out their relative citation index in global context and the unexplored area of research in pharmaceutical science for research grants. Hugar and Chaman 10 evaluated the pharmaceutical research using Web of Science database during 2013-2017 and found that highest numbers of publications were found during 2016. USA leads with 30.2 per cent and National Science Foundation of China is the first funding agency with 4.6 per cent of funding.
Basing on the above literature we found that no such comparison has been made till now which compared the scholarly output and impact of two Asian developing countries i.e. India and China with developed countries like United States in the last two decade. The present study is an attempt in that direction to find out the annual growth rate and citation pattern of the United States, India and China during 1998-2017 and the preferred source of communication and their collaboration patterns.
OBJECTIVES
The main objectives of the study are as follows. To analyse the pattern of collaboration of these countries.
MATERIALS AND METHODS
The study is based on scholarly communication output of pharmaceutical research during the last two decades i.e.1998 to 2017 by India, China and United States as reflected in Scopus database. Scopus is the largest abstracting and citation database of elsevier. A basic search strategy used was -Affil (India) and Doctype ( ar or re ) and Pub year > 1997 and Pub year < 2018 and ( limit-to ( subarea , "phar" ) ). The data for other countries followed the similar search strategy. The citation and bibliographic information extracted was saved in MS Excel-2007 for the purpose of analysis. For accessing the quantity and impact of publications, following bibliometric indicators are used: • Total number of publications (TNP) for measuring the productivity of different countries • Total no of citation (TNC) to measure the impact of output • Citation per paper (CPP) to normalise the variation in output of different countries • h-Index to rate the impact of research.
Activity Index (AI) has been used to normalise the output data, as the absolute research output is affected by the size of the country as well as the size of subfield. The measure was first suggested by Frame 11 and later elaborated by Schubert & all science fields, expressed as percentage. AI=100 indicates that a country's research effort in the given field corresponds precisely to world average. AI>100 reflects higher than average effort and AI<100 indicates lower than the average effort by the country. The whole period of research output of India, China and United States has been divided into four block of 5 year each for the study of relative research. Journal impact factor is used for measuring the journal impact; Higher the Journal impact factor, the better the impact of the journal. The TNP and TNC were calculated directly from the downloaded data. CPP is the average number of citation papers obtained (TNC/TNP). For calculating the h-index, a list of publication was taken and sorted from the highly cited to low cited. The documents were matched until the number of publications matched with the number of citations.
The per cent of growth = End Value -First value / First value ×100
The compound annual growth rate (CAGR) is calculated by taking the n th root of the total percentage growth rate, where n is the number of years taken for the study - Table 1 only United States, UK and Germany had higher value of h-index than the average. It was highest for United States (560) followed by UK (366) and Germany (314).
Preferred Language of Three Leading Countries
The most preferred language for publication of scholarly communication is english for all the three countries. United States publishes mostly in English language (292157) followed by India (112979), China (108220). Chinese Language is mostly preferred by China (50968) followed by United States (263) and India (1) . United States also preferred German Language (197), followed by China (36) and India (3). United States scholarly communication published in Spanish Language (109), Japanese Language (105) and other 19 language (171). China published in Spanish Language (1), Japanese Language (120) and other 5 language (505). India published in Spanish Language (58), Japanese Language (6) and other 9 language (68) as shown in Table 2 .
Preferred Communicating Documents
It has been noticed that an appropriate selective outlet may play an important role in the visibility influence which has great impact over the research article. During the research period as we took only article and review for the study, more than 90 The annual growth rate is highly inconsistence and has fluctuated during the research period for all the three countries because pattern of growth is highly chaotic as shown in Fig.1 . Among all the three countries, China has the highest value of CAGR (14.21) followed by India (8.80) and United States (2.1)
Relative Research Effort of Three Leading Countries
The research output of the India, China and United States from 1998-2017 (20 yrs.) has been presented in four blocks of 5 year each in Table 5 . Activity Index (AI) has been used to calculate the relative research effort of these countries. Likewise, we calculated the value of AI for three countries for other three blocks. It indicates that AI of United States has declined considerably during the last two blocks (2008-2017); whereas that of India and China has increased considerably in last two block in Table 5 .
Citation Impact of Three Leading Countries
The three leading countries together produced 565,714 paper. These papers received 11,851,295 citation with an average of 17.55 citation per paper during the research period. In terms of total citations United States received 8,740,619(73.75 %) of total citation followed by China with (1822827, 15.38 %) and India with (1287849, 10.86 %) as shown in Table 6 . Also, the value of CPP was highest for United States. The value of CPP for India and China was almost equal.
Pattern of Citations
The overall pharmaceutical research output was classified according to the citation range from 1 to >9. During the research period, a larger portion (45.55 %) received citation more than 9. Almost 21 per cent publications received 4 to 9 citation. The share of publications not cited is lowest for the United States. however, the share of not cited publications for India and China did not differ considerably.
Top 20 Preferred Journals of India, China and United States
Journals are the primary source of information as they help researchers to communicate the finding of their research in a faster and effective way. Out of Top 20 preferred journals Table 3 .
Yearly Distribution of Publication Output
During the research period the pattern of scholarly communication and the annual rate of growth of the three leading countries are as represented in Table 4 . India shows a rising trend of Pharmaceutical research output during 2004-2016 with little deviation and a decline has been observed from 2017. The research performance of United States in the year 2014 reached its peak and with little deviation and slowly decreased from 2015. But in case of pharmaceutical research Table 8 , Table 9 and Table 10 presents the top 20 most preferred journals by the scholars in the field of pharmaceutical sciences from India, China and United States. These Tables also gives the TNP, h-Index, IF Values (2016) and Country of its publisher. 
Share of Collaborative Papers in the

CONCLUSIONS
The three leading countries with 565714 publications scored 41 per cent of the global publication which is more than one third of the global pharmaceutical research. In terms of quality and quantity, United States leads in the world. In terms of quantity, India is in 3 rd position in pharmaceutical research 
